CVS vs RAPT · P/E 16, rev $106.10B vs $132.1M cap
CVS Health Corp (CVS) versus RAPT Therapeutics Inc (RAPT) — a side-by-side from cached financials, not a winner call.
CVS Health Corp (CVS) is a healthcare plans company listed on US.
RAPT Therapeutics Inc (RAPT) is a biotechnology company listed on US.
Latest reported CVS revenue for 2026-06-30 was $106.10B. Net income was $2.98B. Revenue was up 5.6% from 2026-03-31 to 2026-06-30. CVS currently screens at market cap $86.20B and trailing P/E 16.3.
Latest reported RAPT revenue for 2023-12-31 was $0. Net income was -$116.8M. Revenue was down 100.0% from 2022-12-31 to 2023-12-31. RAPT currently screens at market cap $132.1M.
CVS currently screens at market cap $86.20B and trailing P/E 16.3. RAPT currently screens at market cap $132.1M.
Not investment advice. Open the CVS and RAPT stock pages for the full models.
Not investment advice.